ClinicalTrials.Veeva

Find clinical trials for Glioblastoma (GBM) in Hanyang, Seoul

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Glioblastoma
Recurrence
Glioma
Brain Cancer
Astrocytoma
Cancer
Gliosarcoma

Glioblastoma (GBM) trials near Hanyang, Seoul, KOR:

GX-I7 in Combination With Bevacizumab in Recurrent Glioblastoma (GBM) Patients

The purpose of this study is to evaluate the efficacy and safety of GX-I7 in combination with bevacizumab in subjects with recurrent glioblastoma...

Active, not recruiting
Recurrent Glioblastoma
Drug: GX-I7
Drug: Bevacizumab

Phase 2

Genexine

Seoul, Korea, Republic of

evaluate the maximum tolerated dose, safety and efficacy of BEY1107 in combination with Temozolomide in Patients with Recurrent or Progressive Glioblastoma...

Enrolling
Glioblastoma Multiforme
Drug: BEY1107
Combination Product: Temozolomide

Phase 1

BeyondBio

Seoul, Korea, Republic of

(TNBC), ovarian cancer, gastric cancer, colorectal cancer (CRC), glioblastoma (GBM), biliary tract cancers (BTC), or pancreatic can...

Active, not recruiting
Glioblastoma
Gastric Cancer
Biological: Pembrolizumab
Drug: Lenvatinib

Phase 2

Merck Sharp & Dohme (MSD)
Merck Sharp & Dohme (MSD)

Seoul, Korea, Republic of and 87 other locations

Researchers are looking for a better way to treat people with solid tumors. Before a treatment can be approved for people to take, researchers do cli...

Active, not recruiting
Solid Tumors
Drug: Regorafenib, (Stivarga, BAY73-4506)
Drug: Nivolumab (Opdivo)

Phase 2

Bayer
Bayer

Seoul, Korea, Republic of and 33 other locations

progression-free survival (PFS) of patients with newly diagnosed glioblastoma multiforme (GBM) can be improved by the addition of i...

Enrolling
Glioblastoma
Radiation: Radiochemotherapy
Procedure: Standard surgery

Phase 3

Universitätsmedizin Mannheim

Seoul, Korea, Republic of and 18 other locations

receptor (EGFR) resistance (EGFR C797S) mutations with or without CNS disease (in Phase 1 and Phase 2), or glioblastoma multiforme (GBM...

Enrolling
Advanced Non-Small Cell Squamous Lung Cancer
Epidermal Growth Factor Receptor C797S
Drug: BDTX-1535 monotherapy

Phase 1, Phase 2

Black Diamond Therapeutics

Seoul, Korea, Republic of and 25 other locations

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems